• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Brad Perriello

Frequency Therapeutics inks $625m deal with Astellas, adds $62m Series C

July 23, 2019 By Brad Perriello

Frequency Therapeutics updated logo

Frequency Therapeutics said today that it raised a $62.0 million Series C round for the hearing loss drug it’s developing and inked a development and overseas distribution deal with Astellas Pharma that’s worth $625 million. Woburn, Mass.-based Frequency drew a $42 million Series B early this year; including the financing announced today, a $32 million […]

Filed Under: Featured, Funding Roundup, Otolaryngology Ear, Nose & Throat, Pharmaceuticals, Wall Street Beat Tagged With: Frequency Therapeutics

Glaukos licenses eye drug-delivery tech from Intratus

July 22, 2019 By Brad Perriello

Glaukos logo

Glaukos (NYSE:GKOS) said today that it inked a licensing deal with Intratus for that company’s transdermal drug delivery platform for treating eye conditions. San Diego-based Intratus developed cream-based drug formulations that are applied to the outer eyelid to treat conditions such as dry eye disease, glaucoma, allergy, blepharitis and conjunctivitis. The deal gives San Clemente, Calif.-based […]

Filed Under: Featured, Optical/Ophthalmic Tagged With: Glaukos, Intratus

Senseonics prices $107m worth of stock, debt offerings

July 18, 2019 By Brad Perriello

eversense-logo

Senseonics (NYSE:SENS) today priced stock and debt offerings worth a total of at least $107 million. Germantown, Md.-based Senseonics, which developed the Eversense implantable CGM, announced the offerings yesterday. Today the company priced $82 million worth of 5.25% convertible senior notes due 2025. Part of the expected $77 million in net proceeds are earmarked for buying […]

Filed Under: Diabetes, Featured, Funding Roundup, Wall Street Beat Tagged With: Senseonics

Senseonics slides on stock, debt offerings, Q2 prelims

July 17, 2019 By Brad Perriello

eversense-logo

Senseonics (NYSE:SENS) shares are off nearly -7% today after the continuous glucose monitor maker revealed plans for a stock and debt offerings and released its preliminary second-quarter sales numbers. Germantown, Md.-based Senseonics, which developed the Eversense implantable CGM, said it plans to float $25 million in stock (plus a 30-day, $3.8 million underwriters option) and $80 […]

Filed Under: Diabetes, Featured, Funding Roundup, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Senseonics

Clearside Biomedical licenses microinjector to Aura Biosciences

July 9, 2019 By Brad Perriello

Clearside Biomedical

Clearside Biomedical (NSDQ:CLSD) said today that it licensed its microinjector technology to Aura Biosciences for use with Aura drug candidates in treating ocular cancers. Alpharetta, Ga.-based Clearside’s Suprachoroidal Space Microinjector is designed to deliver therapeutics into the suprachoroidal space between the sclera and choroid of the eye. Aura, based in Cambridge, Mass., is developing viral nanoparticle […]

Filed Under: Drug-Device Combinations, Featured, Optical/Ophthalmic, Research & Development Tagged With: Aura Biosciences, Clearside Biomedical

AgaMatrix raises $56m for WaveForm CGM

July 3, 2019 By Brad Perriello

AgaMatrix

AgaMatrix said today that it brought in a $56 million funding round for the eponymous continuous glucose monitor its WaveForm Technologies subsidiary is developing. The round, which includes $6 million from new and existing backers and $50 million in senior debt financing from Perceptive Advisors, is slated for paying down debt and increasing production capacity, […]

Filed Under: Diabetes, Featured, Funding Roundup, Wall Street Beat Tagged With: agamatrix, waveformtechnologies

Biocorp, Sanofi ink €4m Mallya sensor deal

July 3, 2019 By Brad Perriello

Sanofi, Biocorp

Biocorp (PAR:ALCOR) said today that it inked a deal with pharma giant Sanofi (NYSE:SNY) to integrate its Mallya sensor into Sanofi’s diabetes management platform. Issoire, France-based Biocorp’s Mallya is designed to clip to an injection pen to automatically log and transmit dosage data. The deal calls for Sanofi to pay Biocorp €4 million, or about $4.5 […]

Filed Under: Diabetes, Featured, Patient Monitoring, Wall Street Beat Tagged With: biocorp, sanofi

BD recalls SmartSite syringe administration set

July 2, 2019 By Brad Perriello

Becton Dickinson

Becton Dickinson (NYSE:BDX) recalled nearly 3,000 leaky SmartSite syringe administration sets used in the neonatal intensive care unit in what the FDA deemed a Class I action. Franklin Lakes, N.J.-based BD issued an urgent medical device recall in February involving 2,900 of its SmartSite syringe administration sets, which are used with infusion pumps to deliver medication, […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Hospital Care, Pediatrics, Recalls, Regulatory/Compliance Tagged With: Becton Dickinson

Livongo Health files for $100m IPO

July 1, 2019 By Brad Perriello

Livongo

Livongo Health last week filed for an initial public offering worth $100 million for the digital health platform it developed to treat chronic diseases. The Mountain View, Calif.-based company’s initial focus on diabetes involves a smart, cellular-connected glucose meter, automatically-delivered testing materials, real-time coaching and full-time monitoring. The system personalizes messages based on each glucose […]

Filed Under: Diabetes, Featured, Funding Roundup, Initial Public Offering (IPO), mHealth (Mobile Health), Wall Street Beat Tagged With: livongohealth

SEC accuses lawyers in $1.7m PixarBio fraud

June 28, 2019 By Brad Perriello

PixarBio

The U.S. Securities & Exchange Commission this week accused a coterie of lawyers of securities fraud in connection with nearly $1.7 million in illicit stock sales involving PixarBio. The scheme began in the fall of 2014, the SEC alleged, when Connecticut lawyer Henry Sargent formed a shell company called BMP Holdings and coaxed $1,680 from […]

Filed Under: Featured, Legal News, Pharmaceuticals, Wall Street Beat Tagged With: PixarBio

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Interim pages omitted …
  • Page 14
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS